Saturday, December 06, 2025 | 07:34 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

This smallcap pharma stock has zoomed 101% in a month

On April 28, Morepen Group sealed $100 million (Rs 750 crore approx.) investment from Corinth Group of Switzerland

paracetamol, pharma, drugs, medicine, health
premium

Representative image

SI Reporter Mumbai
Shares of Morepen Laboratories, on Monday, were locked in 5 per cent upper circuit at Rs 68.65 on the BSE, hitting a 19-year high in an otherwise weak market. The pharmaceutical company's stock is trading at its highest level since May 2002, the BSE data shows.

Till 12:15 pm, a combined 8.2 million equity shares had changed hands and there were pending buy orders for 2.75 million shares on the NSE and BSE. In comparison, the S&P BSE Sensex was down 0.62 per cent at 48,481 points. In the past one month, the market price of Morepen Laboratories has